Business Wire

PastBook Raises $2 Million to Scale-Up its One-Click Photo Books Platform

Del

PastBook, a fast-growing technology company specialized in frictionless photo book creation, announces today it has completed a new investment round of $2M, bringing the total amount raised by the company to over $2.5M.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170921005099/en/

The investment was completed in two tranches: an initial convertible note plus a follow-up investment from existing investors (Vortex Capital Partners and other Dutch high net-worth individuals, mostly successful entrepreneurs).

According to investor Dinko Valerio - Founder and former CEO of Crucell, “As a sparring partner and investor, I am very pleased with the roll-out and success of PastBook. The company is clearly poised for further growth, which is why I am happy to continue my support.

PastBook has been growing exponentially at a rate of 10x YoY in revenue for the last three years in a row, with the majority of customers (80%) being in the USA. The company will use the proceeds of the new investment round to introduce new products and fuel marketing activities for its international expansion through the launch of its Intelligent Instant Photo Book platform in several European countries – including The Netherlands, Germany, France, Italy and the UK – in addition to the USA, Australia and Canada where PastBook already has a significant commercial presence.

Stefano Cutello, Founder and CEO of PastBook says, “With our Intelligent Instant Photo Book solution focused on Facebook and Instagram, we have proven that we’re un-tapping a new segment in the market: people who always wanted to have a photo book but never found the time to make one. With the additional resources now at our disposal, we can go full-steam in developing solutions that cater to their needs.”

The PastBook Intelligent Instant Photo Book platform provides the most frictionless way to create a photo book from any source. PastBook’s own developed algorithm combines a huge range of data with smart technology to automatically select the user’s best photos (with their captions and dates) from a chosen time period and instantly arranges them into a photo book within 60 seconds, without requiring user interaction.

PastBook’s sophisticated technology and algorithms, combined with its one-click photo book creation engine, sets its service apart from its competitors and the more traditional, mainstream, players in the photo book market: 95% of the books sold by PastBook are instant books, i.e. not edited by its customers (having had the option to make changes). For 50% of the PastBook users, their PastBook photo book is the first photo book they have ever created.

PastBook also recently partnered up with RPI, a provider of premium quality photo book printing services with facilities in USA and Europe, along with partner facilities in Oceania. Through this partnership PastBook has been able to expand its global footprint and reduce shipping times.

PastBook is available on web and mobile and on the App Store. An Android version is coming by the end of the year.

ABOUT PASTBOOK - https://www.pastbook.com/

Founded in 2012 in Amsterdam, as part of RockStart Accelerator, PastBook has been named one of the ‘Hottest startup’s in Amsterdam” by Wired, nominated as “Rising Star” by Deloitte (Fast50) and listed as one of the “Top 5 Fastest Growing Tech Companies” by TheNextWeb (Tech5). It has also been featured by Facebook as Marketing Success Story (https://www.facebook.com/business/success/pastbook).

PastBook is on a mission to help people preserve and relive memories, that are nowadays scattered between social networks and devices, by offering the most frictionless experience to create a beautiful photo book in seconds.

PastBook’s Intelligent Instant Photo Book platform automatically and intelligently selects the best photos from designated and instantly arranges them into a beautiful photo book, ready to be printed.

http://www.pastbook.com/txt/press-resources/

Contact information

PastBook BV
Stefano Cutello (Founder & CEO)
+31(0)638123898
stefano@pastbook.com
https://www.pastbook.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers17.2.2018 21:00Pressemelding

Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4). Behçet’s Disease is a rare, chronic, multi-system inflammatory syndrome. Oral ulcers, the most common manifestation of Behçet’s Disease, can be disabling and have a substantial effect on quality of life. This study primarily evaluated the effect of apremilast on recurring oral ulcers in patients with active Behçet’s Disease who were previously treated with at least one topical or systemic medication. “Reducing oral ulcers, which are painful and can negatively im

CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 08:00Pressemelding

Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates

Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 18:26Pressemelding

Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a

General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 17:05Pressemelding

General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges

Systemic Sclerosis World Congress:Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease16.2.2018 09:03Pressemelding

Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/ Anna, 36, living with scleroderma (Photo: Business Wire) The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S. The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact o

Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row16.2.2018 08:00Pressemelding

Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to PMI teams in 44 countries, a testament to the company’s consistency and excellence in offering an enriching and dynamic work environment, and exceptional development opportunities for employees across the globe. PMI has been recognized by the Top Employer Institute for six consecutive years. This year, PMI was awarded with five regional certifications in Europe, the Middle East, Africa and, for the first time, in North America and Latin America. Additionally, Indonesia was the first PMI affiliate to be certified in Asia. “It is a proud moment for all of us at PMI,” said Charles Bendotti, PMI Senior Vice President, People and Culture. “Our success as a company relies on the men and women who come to work every day with a passion to achieve, and a willingness to learn, grow, and